Broadfin Capital’s Rigel Pharmaceuticals RIGL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-312,528
| Closed | -$9.47M | – | 80 |
|
|
2015
Q4 | $9.47M | Sell |
312,528
-200,000
| -39% | -$6.06M | 0.58% | 44 |
|
|
2015
Q3 | $12.7M | Sell |
512,528
-75,147
| -13% | -$1.86M | 0.7% | 30 |
|
|
2015
Q2 | $18.9M | Sell |
587,675
-236,958
| -29% | -$7.61M | 1.01% | 20 |
|
|
2015
Q1 | $29.4M | Sell |
824,633
-25,542
| -3% | -$912K | 2.29% | 10 |
|
|
2014
Q4 | $19.3M | Buy |
850,175
+250,373
| +42% | +$5.68M | 1.68% | 18 |
|
|
2014
Q3 | $11.6M | Buy |
599,802
+40,000
| +7% | +$776K | 1.22% | 24 |
|
|
2014
Q2 | $20.3M | Buy |
559,802
+14,290
| +3% | +$519K | 1.98% | 17 |
|
|
2014
Q1 | $21.2M | Buy |
545,512
+50,000
| +10% | +$1.94M | 2.05% | 14 |
|
|
2013
Q4 | $14.1M | Buy |
495,512
+138,930
| +39% | +$3.96M | 1.86% | 21 |
|
|
2013
Q3 | $12.8M | Buy |
356,582
+51,582
| +17% | +$1.85M | 2.27% | 17 |
|
|
2013
Q2 | $10.2M | Buy |
+305,000
| New | +$10.2M | 1.99% | 17 |
|